Healthcare & Biotech AI

Bausch + Lomb Introduced Orphia™ to Help Physicians Spend More Time with Patients

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced the creation of Orphia™, a new AI-powered digital health platform built on the belief that eye care providers should spend less time managing disconnected tools and technologies and more time caring for patients. The platform is brand agnostic and d

CorePlus Integrated AI-Powered Prostate Cancer Risk Stratification into Digital Pathology

CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced the integration of the ArteraAI Prostate Test into its diagnostic workflows, becoming the first laboratory in Puerto Rico to bring this guideline-recommended AI test into routine clinical use, allowing for fast and convenient delivery of treatment insights. The ArteraAI Prostate Test is an

OpenEvidence and Anticoagulation Forum Formed a Partnership to Enhance AI-Driven Clinical Guidance

OpenEvidence and the Anticoagulation Forum (AC Forum) announced a strategic partnership to provide antithrombotic guidance and tools that support decision-making in clinical practice. By combining the AC Forum’s leadership in education and multidisciplinary clinical guidance with OpenEvidence’s advanced artificial intelligence platform, clinicians will gain access to timely and practic

Altasciences and Evidence Matters Advance AI-Driven Drug Development With Nonclinical Automation Breakthrough

Altasciences, a fully integrated early-phase drug development organization, and Evidence Matters, a pioneer in clinical trial data science, are pleased to announce a successful proof-of-concept (POC) of RegulatoryFlow (“RegFlow”), following the announcement of the companies’ strategic collaboration in August 2025. The POC demonstrated the extension of AI-driven efficien

Aureka Strengthened Its AI Drug Discovery Strategy with the Introduction of OpenDDE

Aureka, an AI TechBio company building infrastructure for AI-driven biologics discovery, announced the release of Open Drug Discovery Engine (OpenDDE), an open-source, all-atom biomolecular foundation model designed to serve as the structural reasoning core of next-generation drug discovery systems. OpenDDE uses biomolecular co-folding as the entry point to model interactions acr

Zanderio Debuted an AI Booking Assistant to Modernize Wellness Clinic Operations

Zanderio has announced the launch of an AI booking assistant for wellness clinics, med spas, aesthetic practices, and other appointment-based service businesses. The assistant is designed to help clinics respond to website enquiries, answer service-related questions, and capture booking requests outside normal front desk hours.Many wellness and aesthetic businesses rely on their websites as a

SK bioscience Introduced an AI Initiative to Strengthen Vaccine Development Decisions

SK bioscience announced that it will lead the Research Optimization & Trial Outcome Recommender (ROTOR) project, an AI-powered evidence synthesis and clinical development decision-support platform initiative funded by the Gates Foundation, establishing a global collaboration framework. The project is expected to involve technical collaboration with global health nonprofit PATH, and global te

DoH Expanded Its AI Healthcare Strategy Through a Partnership with the MIT-Koch Institute

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, and the MIT – Koch Institute for Integrative Cancer Research have announced a strategic collaboration to advance AI-enabled oncology research, translational science and bioconvergence innovation. Leveraging Abu Dhabi's intelligent life science ecosystem, the partnership will connect world

SK bioscience Advanced Vaccine R&D with an AI-Powered Decision Support Initiative

SK bioscience announced that it will lead the Research Optimization & Trial Outcome Recommender (ROTOR) project, an AI-powered evidence synthesis and clinical development decision-support platform initiative funded by the Gates Foundation, establishing a global collaboration framework. The project is expected to involve technical collaboration with global health nonprofit PATH, and global tech

DentScribe Expanded Its Dental AI Platform with Patient Profiles and Treatment Intelligence

DentScribe, the AI platform for dental documentation and production intelligence, announced two new capabilities built for modern dental practices, DSOs, and multi-location groups: DentScribe Patient Profiles and DentScribe Treatment Coordinator Intelligence, including Treatment Coordinator Notes, also known as Financial Notes. Together, the new capabilities help dental o

Vilo Introduced an AI-Native Operating System to Redefine Wearable Technology

Most people who own a smartwatch or ring can tell you their heart rate variability score. Few can tell you what to do about it. Vilo's Signal OS is built for that gap. Vilo, an AI wearable company backed by HongShan Capital (formerly Sequoia Capital China), introduced Signal OS, an AI-native operating system for its upcoming ring-first wearable platform. Designed to move wearables beyond static d

IMU University and NUS-ISS Launch Digital Leadership Program for AI-Driven Healthcare

As healthcare systems across Asia accelerate investments in artificial intelligence (AI), digital platforms, and data-driven care, increasing attention is being placed on the leadership capabilities required to guide transformation and maximise value from these investments. The discussion comes at a pivotal moment for Malaysia as the nation advances its AI agenda as a key driver of economic growt

One Brooklyn Health Selects hellocare.ai to Expand AI-Powered Virtual Care

One Brooklyn Health (OBH), an integrated healthcare system serving Brooklyn, New York, has selected hellocare.ai as its enterprise partner for AI-assisted virtual care delivery. The partnership will bring advanced artificial intelligence capabilities to OBH's clinical teams, enabling scalable, continuous patient monitoring and enhanced care delivery across its hospitals. Through this collaboratio

ProjectLeo Strengthened Digital Patient Engagement with the Introduction of an AI Advocate App

ProjectLeo, launched its AI patient advocacy app on the App Store, giving patients and caregivers a 24/7 independent advocate to navigate appointments, understand medical records, fight insurance denials, and make sense of a healthcare system built for institutions, not individuals. ProjectLeo's AI, Leo, operates across six advocacy modes — Navigator, Ally, Educator, Analyst, Coor

Boltz Strengthened AI-Driven Pharmaceutical Research Through a Takeda Collaboration

Boltz PBC, an applied AI research lab, announced a collaboration with Takeda to deploy Boltz's most advanced biomolecular AI models and platform to scientists across Takeda's Research organization. The collaboration will give Takeda's discovery teams direct access to Boltz's latest proprietary biomolecular foundation models for structure prediction and design, including BoltzMol-1 and BoltzP

Quest Global Launched Neprion to Fast-Track the Future of AI Smart Wearables

Quest Global, the largest independent pure-play engineering services company, announced the launch of Neprion (Next–Gen Product Realization), a framework-led product realization and system validation offering for AI/AR smart glasses and broader AI/AR/XR smart wearables. Quest Global's Neprion is designed to help OEMs, Tier–1 suppliers, and ecosystem partners accelerate

DeepIntent Launched Helix AI to Redefine Healthcare Marketing Through Agentic AI

DeepIntent, the leading healthcare demand-side platform (DSP), launched Helix AI, the first agentic AI platform purpose-built for healthcare marketers. Helix AI unlocks market insights buried within the industry's most trusted and comprehensive health datasets, enabling marketers to strategize and engage key audiences with unprecedented precision across DeepIntent's DSP as well as other channels,

Tempus Announced Clinical Validation of AI ECG Model for Atrial Fibrillation Risk Prediction

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, announced publication of successful multi-site validation of its software, which received U.S. Food and Drug Administration clearance in 2024 for predicting the one-year risk of atrial fibrillation or flutter (AF). The study, titled "Multi-Center Validation of an Artificial Intelligen

Converteo Introduced an International AI and Agentic Systems Practice Focused on Pharma and Life Sciences

Converteo, a leading consulting firm specializing in data and artificial intelligence, announced the launch of a service and solution offering for production-grade AI dedicated to the Pharma & Life Sciences sector. Since 2024, the pharmaceutical sector has become one of the world's largest investors in AI. In an environment shaped by increasing regulatory demands, cost pressures, a

Vega Health and Parkland Center for Clinical Innovation Launched Strategic Partnership to Improve Care for High-Risk Populations

Vega Health, the end-to-end AI partner for health systems navigating the complexity of AI adoption and scaling, announced a licensing agreement with Parkland Center for Clinical Innovation (PCCI). PCCI is a non-profit research and development organization that brings unparalleled expertise in applying AI and social determinants of health (SDoH) to improve outcomes for vulnerable populations. The p

Karias Health Strengthened Digital Care Innovation With Introduction of Faith AI Companion

Karias Health formally announced Faith, an AI care companion that has launched with their members. Faith helps patients understand what happens during medical visits and act on it immediately - serving as a single source of truth across the care journey, connecting provider instructions, member benefits, and care navigation into one integrated system that cuts through healthcare fragmentation

Talkspace Introduced ‘Tee,’ a Safe AI Agent for Everyday Mental Health Support

Talkspace (NASDAQ: TALK), a leading online behavioral healthcare provider, announced Tee, a safe, fine-tuned large language model developed by mental health experts. With HIPAA-grade privacy protections, Tee has the ability to identify potential suicide risk, homicidal/violence risk, abuse risk and seven other mental health risk entities. It is the first model of its kind providing real-time over